Reliability of Muscle Strength and Activation Assessment Tools and Effects of an Online Therapeutic Exercise Program in Patients With Chronic Kidney Disease
NCT ID: NCT07292311
Last Updated: 2025-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
50 participants
INTERVENTIONAL
2025-11-07
2026-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This two-phase observational and interventional study, conducted in collaboration with the ALCER Association (Badajoz and Cáceres, Spain), will:
1. Determine the test-retest reliability of muscle assessment tools (isokinetic dynamometer, surface electromyography, and handheld dynamometry).
2. Implement and evaluate an online therapeutic exercise program supervised by physiotherapists.
The project aims to provide valid and reliable protocols for neuromuscular assessment in CKD patients and explore the feasibility of remote therapeutic exercise.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reliability Assessment
Test-retest reliability of isokinetic and surface EMG measurements in upper limb, trunk, and lower limb
Reliability Assessment
Device: Isokinetic dynamometer and mDurance® surface EMG Test-retest reliability of isokinetic and surface EMG measurements in upper limb, trunk, and lower limb
Online Therapeutic Exercise
8-10 week supervised online program including resistance and mobility exercises
Online Therapeutic Exercise
Behavioral: Online therapeutic exercise program 8-10 week supervised online program including resistance and mobility exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reliability Assessment
Device: Isokinetic dynamometer and mDurance® surface EMG Test-retest reliability of isokinetic and surface EMG measurements in upper limb, trunk, and lower limb
Online Therapeutic Exercise
Behavioral: Online therapeutic exercise program 8-10 week supervised online program including resistance and mobility exercises
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of chronic kidney disease (hemodialysis, peritoneal dialysis, or kidney transplant).
* Member of ALCER Association (Badajoz or Cáceres).
* Medical clearance for physical testing/exercise.
Exclusion Criteria
* Unstable cardiovascular or musculoskeletal conditions.
* Refusal to provide informed consent.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Extremadura
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alejandro Caña Pino
Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Facultad de Enfermería y Terapia Ocupacional
Cáceres, Cáceres, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
071125
Identifier Type: -
Identifier Source: org_study_id